For example, 5-year survival for colon cancer was greater than 90% for stage I disease but less than 10% for stage IV disease (57); 80% of breast cancers are estrogen receptor positive (58), the survival rate for which is higher than for estrogen receptor–negative cancer (59,60). Here, ESR1 is linked to breast carcinoma.